Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.0K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.0K
Binomial Probability Distribution01:15

Binomial Probability Distribution

15.3K
A binomial distribution is a probability distribution for a procedure with a fixed number of trials, where each trial can have only two outcomes.
The outcomes of a binomial experiment fit a binomial probability distribution. A statistical experiment can be classified as a binomial experiment if the following conditions are met:
There are a fixed number of trials. Think of trials as repetitions of an experiment. The letter n denotes the number of trials.
There are only two possible outcomes,...
15.3K
Randomized Experiments01:13

Randomized Experiments

8.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.8K
Statistical Hypothesis Testing01:16

Statistical Hypothesis Testing

6.1K
Hypothesis testing is a critical statistical procedure facilitating informed, evidence-based decisions. It begins with a hypothesis, which is a tentative explanation, or a prediction about a population parameter. This hypothesis can be either a null hypothesis (H0), indicating no effect or difference, or an alternative hypothesis (Ha), suggesting an effect or difference.
Statistical significance measures the probability that an observed result occurred by chance. If this probability, known as...
6.1K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

244
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
244
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.1K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Per- and Polyfluoroalkyl Substances (PFAS)-Contaminated Hypersaline Brine by Membrane Distillation.

ACS environmental Au·2026
Same author

Clinical and Angiographic Imaging Features of Isolated Cortical Venous Thrombosis.

Stroke (Hoboken, N.J.)·2026
Same author

The Interface of Trauma Surgery and Interventional Radiology: The Trauma Surgeon's Perspective.

Seminars in interventional radiology·2025
Same author

Adopting the estimand framework in prophylactic vaccine trials.

Vaccine·2025
Same author

Comparison of Classical P81 and SVI-P Cation-Exchange Papers in Radiometric Protein Kinase Assays.

The Biochemical journal·2025
Same author

Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma.

Arthritis care & research·2025
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K

A Generalized Bayesian Hierarchical Model in Basket Trials.

Ruoxuan Xiang1, John Scott1

  • 1Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), Silver Spring, Maryland, USA.

Pharmaceutical Statistics
|October 27, 2025
PubMed
Summary
This summary is machine-generated.

A new generalized Bayesian hierarchical model (GBHM) improves upon standard models for oncology basket trials. It robustly handles treatment effect variations across cancer types, offering simpler implementation and better error control.

Keywords:
Bayesian hierarchical modeladaptive designbasket trialsinformation borrowing

More Related Videos

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.3K

Related Experiment Videos

Last Updated: Jan 14, 2026

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.7K
A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.3K

Area of Science:

  • Oncology
  • Biostatistics
  • Clinical Trial Design

Background:

  • Basket trials in oncology evaluate single treatments across multiple cancer types with shared genomic alterations.
  • Standard Bayesian hierarchical models (BHM) borrow information across cancer types but struggle with adaptive borrowing strength and Type I error inflation when treatment effects vary.
  • Existing BHM variations attempt to account for heterogeneity but may require complex modifications or hyperparameter tuning.

Purpose of the Study:

  • To propose a generalized Bayesian hierarchical model (GBHM) that relaxes variance parameter assumptions in standard BHMs.
  • To evaluate the performance of the GBHM against existing BHM variants using extensive simulations based on established study designs.
  • To assess the robustness of the GBHM to treatment effect heterogeneity across different cancer histologies.

Main Methods:

  • Developed a generalized Bayesian hierarchical model (GBHM) by relaxing the variance parameter assumption of the standard BHM.
  • Conducted four simulation studies mirroring setups from existing BHM variant publications.
  • Investigated the GBHM with Inverse-Gamma (IG) and Cauchy priors, exploring various hyperparameters.

Main Results:

  • The GBHM demonstrated robustness to treatment effect heterogeneity with specific prior choices.
  • GBHM with IG(0.01,0.01) prior allows for liberal information borrowing, suitable when Type I error is less critical.
  • GBHM with Cauchy(25) prior provides conservative borrowing, recommended for situations prioritizing Type I error control.

Conclusions:

  • The proposed GBHM offers a flexible and robust alternative to existing models for oncology basket trials.
  • GBHM simplifies implementation compared to other methods, avoiding complex prior specifications.
  • The choice between IG and Cauchy priors allows tailoring information borrowing strength based on study objectives.